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Abstract
A new human oral challenge model with wild-type Salmonella Typhi (S. Typhi) was recently
developed. In this model, ingestion of 104 CFU of Salmonella resulted in 65% of subjects de-
veloping typhoid fever (referred here as typhoid diagnosis -TD-) 5–10 days post-challenge.
TD criteria includedmeeting clinical (oral temperature38°C for12h) and/or microbiolog-
ical (S. Typhi bacteremia) endpoints. One of the first lines of defense against pathogens are
the cells of the innate immune system (e.g., monocytes, dendritic cells -DCs-). Various
changes in circulating monocytes and DCs have been described in the murine S. Typhimur-
iummodel; however, whether similar changes are present in humans remains to be explored.
To address these questions, a subset of volunteers (5 TD and 3 who did not develop typhoid
despite oral challenge -NoTD-) were evaluated for changes in circulating monocytes and
DCs. Expression of CD38 and CD40 were upregulated in monocytes and DCs in TD volun-
teers during the disease days (TD-0h to TD-96h). Moreover, integrin α4β7, a gut homing mol-
ecule, was upregulated onmonocytes but not DCs. CD21 upregulation was only identified in
DCs. These changes were not observed among NoTD volunteers despite the same oral chal-
lenge. Moreover, monocytes and DCs from NoTD volunteers showed increased binding to S.
Typhi one day after challenge. These monocytes showed phosphorylation of p38MAPK,
NFkB and Erk1/2 upon stimulation with S. Typhi-LPS-QDot micelles. In contrast, monocytes
from TD volunteers showed only a moderate increase in S. Typhi binding 48h and 96h post-
TD, and only Erk1/2 phosphorylation. This is the first study to describe different activation
and migration profiles, as well as differential signaling patterns, in monocytes and DCs which
relate directly to the clinical outcome following oral challenge with wild type S. Typhi.
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Author Summary
Typhoid fever continues to be a public health problem and novel more effective vaccines
are needed. One of the limitations in the development of new vaccines is an incomplete
understanding of the host-pathogen interactions. To gain new insights into these interac-
tions a new human oral challenge model with wild-type Salmonella Typhi (S. Typhi) was
recently developed. In this model, 65% of the challenged subjects developed typhoid fever
(referred here as typhoid diagnosis-TD-). Monocytes and dendritic cells (DCs) are part of
the innate immune system and one of the first lines of defense against pathogens. The
changes induced in these cells by S. Typhi infection were studied in a subset of volunteers
(5 TD and 3 who did not develop TD despite the same oral challenge-NoTD-). Monocytes
and DCs showed upregulation of different activation molecules between TD and NoTD
volunteers. Furthermore, monocytes from NoTD volunteers showed enhanced S. Typhi
binding and activation of signaling pathways associated with the pattern recognition re-
ceptor (PRR) TLR4, one day after challenge. In contrast, monocytes from TD volunteers
had a moderate increase in S. Typhi binding and different signaling profiles. Therefore,
multiple differences in monocytes and DCs from TD and NoTD volunteers following wild
type S. Typhi challenge were identified.
Introduction
Typhoid fever caused by Salmonella enterica serovar Typhi (S. Typhi), a human-restricted
pathogen, continues to be a major global public health problem [1, 2]. Due in part to the ab-
sence of a suitable animal model, several aspects of the human response to infection remain to
be explored [3, 4]. Over forty years ago, a successful human challenge model, which helped to
address some aspects of the host-pathogen interaction, was developed at the University of
Maryland [3, 5]. In that model volunteers ingested S. Typhi (107 colony-forming units (CFU)
of wild-type S. Typhi) suspended in 45 mL of milk (without sodium bicarbonate) and 50% of
participants developed clinical infection [3]. Data obtained from this model were critical for
the development of vaccines (Ty21a), diagnostics and treatment [6–10]. A new controlled
human infection model of S. Typhi was recently developed at the Centre for Clinical Vaccinol-
ogy and Tropical Medicine, University of Oxford. In this novel outpatient model, participants
challenged with 104 CFU of S. Typhi (Quailes strain) in a sodium bicarbonate buffered solution
resulted in 65% of participants being diagnosed with typhoid fever (referred here as typhoid di-
agnosis-TD-) [11].
One of the first lines of defense against pathogens are the cells of the innate immune system,
including macrophages and dendritic cells (DCs). Circulating monocytes, derived from bone
marrow precursors, show great plasticity and are able to differentiate into various types of mac-
rophages and DCs as they migrate to tissues or when exposed to the appropriate cytokine envi-
ronment [12–15]. S. Typhi in an intracellular pathogen that initially gains access to the host by
the oral route. Several aspects of the pathogenesis of Salmonella have been elucidated in the
mouse model using S. Typhimurium, which replicates some aspects of human typhoid disease
(typhoid fever-like disease in mice) [16, 17]. For example, it has been demonstrated that S.
Typhimurium invades M and epithelial cells of the gut. Subsequently, the bacteria pass through
Peyer’s patches (PP), mesenteric lymph nodes (MLN), lymphatic vessels and the blood stream
[18, 19]. Monocytes, most likely migrating from peripheral blood, have been shown to accumu-
late in PP and MLN following infection with S. Typhimurium [20]. DCs have been proposed to
play an important role in the pathogenesis of S. Typhimurium by transporting the bacteria
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from the intestine to MLN and other lymphoid tissues [21]. The complement system is likely
to enhance bacterial phagocytosis through opsonization mediated by C3b and C3d, which has
been proposed as one of the mechanisms that allows Salmonella to reach an intracellular niche
within macrophages and polymorphonuclear cells [22]. In rodents it has been demonstrated
that the control of S. Typhimurium growth in the early phases of a primary infection requires
reactive oxygen intermediates generated via the phagocyte NADPH oxidase [23], which is pres-
ent in macrophages. Despite these advances in the role that monocytes, macrophages and DCs
play in the murine typhoid model, whether similar mechanism(s) are operational in human ty-
phoid disease remain to be elucidated. Evaluation of these phenomena in humans has been im-
paired since specimens from humans infected with wild-type (wt) S. Typhi immediately upon
infection are exceedingly difficult to obtain and 40 years ago, when the last human challenges
with wt S. Typhi were performed, the technology was not in place to evaluate these cells in de-
tail. The development of a new human infection model of typhoid fever has provided a unique
opportunity to begin exploring important questions about the role of circulating monocytes
and DCs in this disease. In the current study we report changes in activation, migration and af-
finity for the pathogen in circulating monocytes of participants with typhoid diagnosis (TD)
and those who did not developed disease (NoTD) following wild-type challenge with S. Typhi.
Methods
Human volunteers and clinical trial description
Samples used in this study were obtained as part of a clinical trial aimed at establishing a
human model of S. Typhi infection. The study was performed at the Centre for Clinical Vacci-
nology and Tropical Medicine, University of Oxford, United Kingdom. Details of the clinical
outcomes of this challenge model have already been published [11]. In short, healthy adults
18–60 years-old with no previous history of typhoid vaccination or residence (>6 months) in
endemic areas were included. S. Typhi (Quailes strain) inocula were freshly prepared prior to
each challenge by defrosting and suspending the required number of bacteria in 30 mL/0.53 g
NaHCO3(aq). Participants fasted for 90 minutes before ingesting 120 mL/2.1 g NaHCO3(aq).
Two minutes later, participants ingested the prepared challenge suspension. Volunteers were
challenged either with 103 or 104 CFU of S. Typhi. Typhoid diagnosis included meeting clinical
(temperature 38°C sustained for 12 hours) and/or microbiological (blood culture con-
firmed S. Typhi bacteremia) endpoints. Participants were reviewed daily for at least 14 days, re-
cording the duration and severity of all solicited and unsolicited symptoms experienced and
daily oral temperature readings (2 times per day). Indications for antibiotic treatment (cipro-
floxacin, 500 mg twice daily, 14 days) included reaching typhoid diagnosis, unmanageable
symptoms, or clinical necessity. All participants who did not develop typhoid received antibiot-
ic treatment at day 14. Subsequent visits were performed at 21 and 28 days after challenge. In
the current report we describe the results from a subset of volunteers challenged with 104 CFU
of S. Typhi. In this subset (n = 8), 5 volunteers were diagnosed with typhoid disease (TD) and 3
were not (despite a similar inoculum-NoTD-). In this exploratory study, specimens from a ran-
dom subset of S. Typhi challenged participants were selected based on the number of existing
peripheral blood mononuclear cells (PBMC) and the availability of as many of the critical time
points as possible to enable a comprehensive evaluation of innate immune responses.
Ethics statement
The clinical portion of the study was performed at the Centre for Clinical Vaccinology and
Tropical Medicine, University of Oxford, United Kingdom [11]. Written informed consent
was obtained from all volunteers and the procedures approved by the Oxfordshire Research
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Ethics Committee A (10/H0604/53) and the trial registered on the UK Clinical Research Net-
work (identifier UKCRN ID 9297). Additionally, PBMC collected from healthy adult volun-
teers, recruited from the Baltimore-Washington area and University of Maryland, Baltimore
campus, were also used in this study to characterize monocytes and DCs. Written informed
consent was obtained from all volunteers and the procedures approved by the University of
Maryland, Baltimore IRB (HCR-HP-00040025-6).
Isolation of peripheral blood mononuclear cells (PBMC)
PBMC were isolated from blood samples collected from volunteers challenged with S. Typhi
(Quailes strain). Sample collection was performed before challenge and at various time points
thereafter. The evaluated time points differed slightly between TD and NoTD volunteers.
These included day 0 (pre-challenge) and days 1, 2, 4, 7, 9, 14, 21 and 28 after challenge in all
subjects. However, in TD volunteers extra samples were collected at the time of typhoid diag-
nosis (6–9 days after challenge with 104 CFU of wt S. Typhi, [11]) as well as 48 and 96 hours
later. PBMC were isolated immediately after blood draws by density gradient centrifugation
and cryopreserved in liquid nitrogen following standard techniques [24].
Cell surface staining for flow-cytometry
Cryopreserved PBMC were thawed and allowed to rest overnight at 37°C, 5% CO2 in complete
media [RMPI (Gibco, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Gemini
Bioproducts, West Sacramento, CA), 2 mM L-glutamine (Gibco, Grand Island, NY, USA), 1x
non-essential amino acids (Gibco, Grand Island, NY, USA), 10 mMHEPES (Gibco, Grand Is-
land, NY, USA), 2.5 mM Sodium pyruvate, (Lonza, Walkersville, MD, USA), 100 U/ml Penicil-
lin, 100 ug/ml streptomycin (Sigma-Aldrich, St. Louis, MO, USA), 50 μg/ml Gentamicin
(Gibco, Grand Island, NY, USA)]. Cells were then harvested and stained for flow-cytometry in
V-shaped 96-well plates using methods previously described [24, 25]. Briefly, 1x106 cells were
plated and stained for viability (20 min on ice) using 100 μl of Alexa Fluor 700-succinimidyl
ester dye (0.4 μg/ml) (Invitrogen, USA). After 2 washes with flow cytometry staining (FC) buff-
er (4% FCS, 1X phosphate buffered saline (PBS) and 0.02 Sodium Azide), S. Typhi (strain Ty2)
labeled with Pacific Blue dye (S. Typhi-PB) were added. Bacteria were labeled as previously de-
scribed [26] and used at a 50:1 (bacteria:cells) ratio (20 min on ice). Cells were washed twice
with FC buffer and then blocked with a mixture of mouse IgG (25 μl of a 200 μg/ml solution in
FC buffer) (Meridian Life Sciences, Memphis, TN, USA) and human IgG (25 μl of a 1 mg/ml
solution in FC buffer) (Sigma, St Louis, MO) for 10 minutes on ice. Cells were then stained with
various antibody cocktails prepared in FC buffer. Monoclonal antibodies (mAbs) against the
following molecules were used: CD19-ECD (clone J3-119; Beckman Coulter-BC-),
CD38-PE-Cy5 (clone LS1298-4-3; BC), CD14-QDot 655 (clone TuK; Invitrogen),
CD21-BV711 (clone B-ly4; BD), integrin α4β7-Alexa647 (clone ACT-1; Millennium, The
Takeda Oncology Co), CD3-Alexa Fluor 700 (clone UCHT1; BD), CD66b-FITC (clone G10F5;
BD), CD16-PE (clone 3G8; BD), HLA-DR (clone G46-6; BD), CD56 (clone B159; BD), CD11c-
FITC (clone B-ly6; BD), CD123-PE (clone 9F5; BD), CD1c-APC (BDCA1; clone AD5-8E7; Mil-
tenyi Biotec-MB-), CD303-Biot (BDCA2; clone AC144; MB) and CD141-VioBlue (BDCA3;
clone AD5-14H12; MB). After washing cells twice with FC buffer, Pacific Orange-Streptavidin
was added to each well (Invitrogen, USA). Stained cells were fixed with 1% PFA in PBS.
Phosphoflow assay
Stimulants used. PBMC were stimulated with S. Typhi-LPS-QDot655 micelles of nano-
particle size (approx. 30–60 nm) [27]. To generate LPS-micelles, a previously published
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methodology was used [27–29]. In short, decane was evaporated from 100 μl of organic
Quantum dots (QDots) 655 Innovator’s Tool Kit (ITK) (Invitrogen, Eugene, Oregon) using a
speed vacuum concentrator. QDots were then re-suspended in 500 μl of chloroform. LPS
from S. Typhi (1 mg re-suspended in 100 μl of endotoxin free water) (Sigma-Aldrich,
St. Louis, MO) was then added, followed by methanol (dropwise) until a homogenous mix
was achieved. Methanol was then allowed to evaporate from the LPS-QDot mix and re-sus-
pended in 100 μl of endotoxin free water. The pH of the solution was basificated (pH 11) by
adding a Tetramethylammonium hydroxide pentahydrate solution (100 mM) dropwise. The
solution was then sonicated for 30 minutes and passed through two consecutive Zeba desalt-
ing columns (Pierce, Rockford, IL) to remove salts and excess of free LPS. LPS-micelles were
collected in a total volume of 200 μl. Formation of LPS-micelles was determined by flow cy-
tometry and the LPS concentration by LAL Chromogenic Endotoxin Kit (Pierce, Rockford,
IL). PBMC were stimulated with approximately 5 μg of LPS. As a positive stimulation control
6 mMH2O2, a general phosphatase inhibitor, was used. 1% BSA in PBS was used as a negative
stimulation control.
Cell stimulation and staining. Thawed PBMC were allowed to rest overnight in complete
media at 37°C, 5% CO2. Cells were then plated in 12x17 mm tubes (1x10
6 per reaction) and
stained for viability using a yellow-fixable dye (Invitrogen, USA) (20 min on ice). After 2
washes with 1% BSA in PBS cells were re-suspended in 50 μl of ice cold 1% BSA and allowed to
rest for at least 15 minutes. During this period stimulants were prepared freshly in 1% BSA in
PBS. Stimulant aliquots (50 μl) were maintained at room temperature and added to the chilled
PBMC. Cultures were then immediately transferred to a water bath (37°C) for 10 minutes.
After stimulation, cells were fixed with 1 ml of 1.6% PFA at 37°C (5–10 min) and washed twice
with FC buffer. Fixed cells were permeabilized with 80% ice cold methanol (1 ml) for 20 min-
utes at -20°C. To rehydrate PBMC, samples were washed twice with FC buffer. Samples were
then blocked with a mixture of human and mouse IgG as described above and subsequently
stained with mAb cocktails in FC buffer for 1 hour on ice in the dark. mAbs in the cocktails in-
cluded: CD27-PE (clone L128; BD), pAKT-S473-Ax647 (clone D9E; Cell Signaling Technolo-
gies), CD20-PerCP-Cy5.5 (clone H1; BD), p38MAPK-T180/Y182-Pacific Blue (clone 36/p38
(pT180/pY182); BD), Erk1/2-T202/Y204-PE-CF594 (clone 20A; BD), p38MAPK-T180/Y182-
PE-CF594 (clone 36/p38 (pT180/pY182), Btk-Y551-Alexa647 (clone BtkY551 & ItkY511; BD)
and/or NFκB p65-pS529-PE-Cy7 (clone K10-895.12.50 (pS529; BD). After incubation cells
were washed twice with FC buffer, fixed with 1% PFA in 1X PBS/EDTA and samples collected
in a custom LSRII flow cytometer analyzer (Beckton-Dickson, USA). Samples were analyzed
using FlowJo (Tree Star, San Francisco, CA) and Cytobank (Palo Alto, CA) software packages.
Statistical methods
The percentages of monocytes and DCs in TD and NoTD volunteers before challenge were
compared using the Mann-Whitney test. In challenged volunteers who developed typhoid, the
data was plotted relative to the time of diagnosis (TD). All volunteers were diagnosed with ty-
phoid 5–10 days post-challenge (104 CFU); however, since not all volunteers developed ty-
phoid at the same time, the data was grouped in narrow time frames (e.g., -8 to -6) to facilitate
analysis and interpretation of the data. In NoTD volunteers the data is presented as a time fol-
lowing challenge. Changes in the expression of markers pre-challenge and post-challenge (at
different time frames) were evaluated by one way ANOVA followed by a Dunnett’s post-test
using pre-challenge as the comparator. For comparison of the groups of cells expressing multi-
ple markers a one way ANOVA followed by a Bonferroni’s multiple comparison test was done.
Statistical analysis was performed in GraphPad Prism software (GraphPad Software Inc.,
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USA). All hypotheses were evaluated using two-sided tests. Two-sided p values<0.05, without
adjustment for multiple comparisons, were considered statistically significant.
Results
Changes in activation and gut homing markers induced by S. Typhi in
circulating monocytes
Monocytes (CD14+ CD16+HLA-DR+ CD56- CD66b- CD3- CD19-) were identified in the non-
lymphocytic region of the FSC/SSC bi-exponential plots (Fig 1). No significant differences were
observed in the percentages of monocytes recorded before S. Typhi challenge between partici-
pants who developed TD and those who did not (NoTD) upon challenge with wt S. Typhi (Fig
2A). We next assessed changes in the percentage of monocytes after challenge. No changes were
observed in TD volunteers until 2 days after typhoid diagnosis (TD-48h), when a small reduction
in the percentage of these cells was noted (Fig 2B). The reductions in the percentages of mono-
cytes appeared to persist for several days; however, the differences compared to pre-challenge
were not statistically significant. The frequency of these cells began to return to baseline levels 18
days after diagnosis. In contrast, no changes in the frequency of monocytes following challenge
were recorded in NoTD volunteers (Fig 2C). Interestingly, the number of circulating monocytes
measured in whole blood (whole blood cell counts-WCC-) [11] did not show significant changes
compared to pre-challenge levels in either TD or NoTD participants, although a small decrease
was observed in TD participants starting 8 days after diagnosis (S1A and S1B Fig).
To determine levels of activation of monocytes, changes in the expression of CD38 and
CD40 were evaluated (Fig 3). TD volunteers showed an increase in the expression of CD38 and
Fig 1. Gating strategy. Stained PBMCwere gated on cells with high FSC and SSC characteristics avoiding the lymphocyte region (A), doublets/multiplets
were eliminated (B) and subsequently live cells were gated based on expression of CD14 (C). The viability channel (live/dead-L/D-) also contained CD3;
therefore cells selected were also CD3- (C). CD14+ cells also expressed CD16 and HLA-DR. Therefore, these cells were classified as monocytes (D). All
CD3-CD14- expressed HLA-DR and a percentage of these cells expressed either CD11c or CD123 but lacked CD19, CD66b, CD16 and CD56; therefore,
these cells were classified as dendritic cells (DC) (E) (see also S4 Fig). The identity of these cells as DCs was confirmed using PBMC from healthy volunteers
stained with monoclonal antibodies to BDCA-1, BDCA-2 and BDCA-3 (S4 Fig). Plots shown are from a representative volunteer. Gray histograms represent
fluorescent minus one (FMO) samples.
doi:10.1371/journal.pntd.0003837.g001
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CD40 at the time of typhoid diagnosis or in subsequent days (Fig 3A and 3D). Both markers
showed a peak up-regulation at TD-48h, which was statistically significant, compared to pre-
challenge levels (Fig 3B and 3E). In subsequent days, CD38 and CD40 expression returned to
baseline levels (Fig 3A and 3D). In contrast, no changes in these markers were observed in
NoTD volunteers (Fig 3C and 3F). Furthermore, changes in the expression of integrin α4β7 fol-
lowing challenge were evaluated to determine whether these activated monocytes have the po-
tential to migrate to the gut. Similar to observations with CD38 and CD40, TD volunteers up-
regulated this marker during disease reaching peak levels TD-48h, at which time point the dif-
ferences were statistically significant compared with pre-challenge (Fig 3G and 3H). No
changes in the expression of this marker were identified in NoTD volunteers (Fig 3I).
Ability of monocytes to bind S. Typhi and activation of signaling
pathways
We next evaluated the ability of circulating monocytes to bind S. Typhi. These key innate im-
mune cells are likely to interact with S. Typhi LPS (the most abundant antigen on the surface of
the bacteria) through TLR4, which is expressed by monocytes [30, 31]. Interaction of circulat-
ing monocytes with S. Typhi was evaluated by measuring changes in the relative abundance of
the bacteria on the surface of the cells as determined by changes in mean fluorescence intensity
(MFI) (Fig 4). In TD volunteers an increase in the interaction of monocytes with S. Typhi was
apparent 48–96 hours after TD (TD-48h and TD-96h) (Fig 4A). It is of importance to notice
that these are the same time points in which the other parameters evaluated also showed the
most significant changes. Detailed analysis at TD-48h post-diagnosis in TD volunteers revealed
that 2 of 4 volunteers showed increased ability to bind S. Typhi (Fig 4B). To evaluate if the in-
creased binding of monocytes for S. Typhi resulted in increased activation of these cells,
Fig 2. Monocyte levels in peripheral blood following infection with wt S. Typhi. The percentages of circulating monocytes in TD (circles; n = 5) and
NoTD (triangles; n = 3) participants were compared to the levels before wt S. Typhi challenge (A), as well as in subsequent days (B andC). In TD volunteers
(B), the data is depicted relative to the time of typhoid diagnosis (TD) (dotted vertical line). Time points before (except for pre-challenge) and after (>+7 days)
TD were depicted in narrow time frames whilst TD, TD-48h and TD-96h are shown as individual time points. Mean ± SE are presented in all graphs.
doi:10.1371/journal.pntd.0003837.g002
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phosphorylation of signaling pathways associated with TLR4 [NFκB-p65 (pS529), Erk1/2
(T202/Y204) and p38MAPK (pT180/pY182)] were studied using S. Typhi LPS-micelles as the
stimulant (10 min, 37°C). The results showed that in TD volunteers, the monocytes of the 2
volunteers with enhanced avidity for S. Typhi (peak at TD-48h) phosphorylated Erk1/2 (T202/
Y204), only one of them NFκB-p65 (pS529), but none of them p38MAPK (pT180/pY182) (Fig
4C). In contrast, in NoTD volunteers a spike in the interaction with S. Typhi by monocytes was
Fig 3. Changes in CD38, CD40 and integrin α4β7 expression in monocytes following wt S. Typhi challenge. Shown in panelA, D andG are time
courses of the changes in CD38, CD40 and integrin α4β7 expression, respectively, in TD volunteers. Shown in panelsB, E andH are the data in individual
volunteers at pre-challenge (circles) and peak up-regulation (TD-48h) (black diamonds) for these markers in TD volunteers. The histogram insert contains an
example of the up-regulation of each marker in a representative volunteer. Shown in panelsC, F and I are the time courses of the expression of CD38, CD40
and integrin α4β7 in NoTD volunteers. Statistical significance compared to pre-challenge is indicated by: * p<0.05; **p<0.005 (Dunnett’s multiple
comparison test).
doi:10.1371/journal.pntd.0003837.g003
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also noted; however, this was present immediately after challenge (D1) (arrow) (Fig 4D) and all
the NoTD volunteers showed this increased interaction. Furthermore, monocytes of these vol-
unteers phosphorylated all the signaling proteins evaluated (NFκB-p65, Erk1/2 and
p38MAPK) at the peak interaction time with S. Typhi (D1 post-challenge) (Fig 4E).
Changes in activation markers induced by S. Typhi in circulating DCs
Similar to monocytes, DCs (HLA-DR+ CD11c+/- CD123+/- CD14- CD3- CD19- CD16- CD56-
CD66b-) were identified in the non-lymphocytic region of the FSC/SSC bi-exponential plots
(Fig 1). Furthermore, comparable to the observations with circulating monocytes, no differ-
ences in the percentage of DCs were observed in TD and NoTD participants before challenge
with wt S. Typhi (Fig 5A). Additionally, neither TD nor NoTD volunteers showed changes in
the percentage of DCs in the days after challenge (Figs 5B and 3C). In TD volunteers, the acti-
vation markers CD38 and CD40 were significantly up-regulated in DCs at the time of typhoid
diagnosis or in the subsequent 96 hours (Fig 6A and 6D). The peak increase of these molecules
was TD-48h and TD for CD38 and CD40, respectively, at which time point the differences
were statistically significant compared to pre-challenge (Fig 6B and 6E). Up-regulation of these
Fig 4. Ability of monocytes to bind S. Typhi and activation of signaling pathways following wild-type challenge. Time courses of S. Typhi (killed-
fluorescently labeled) binding to circulating monocytes from TD (A) and NoTD (D) volunteers. Shown in panelsB and E are the binding data of individual
volunteers at the peak time for TD (TD-48h) and NoTD (D1 Post-challenge) participants, respectively. Each volunteer is indicated by a defined symbol and
color, which is also used to represent the data in panelsC and F. The horizontal solid lines indicate the mean. Shown in panelsC and F are the
phosphorylation profiles of Erk1/2, pNFκB and p38MAPK following stimulation with S. Typhi-LPS QD-655micelles in TD and NoTD volunteers, respectively,
at peak avidity. The data is presented as fold changes at peak S. Typhi binding compared to pre-challenge. The dotted line indicates no changes in
phosphorylation and the horizontal lines represent the mean.
doi:10.1371/journal.pntd.0003837.g004
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markers was not detected in DCs of NoTD volunteers (Fig 6C and 6F). We also evaluated
changes in the expression of CD21 induced by S. Typhi challenge. Results showed that a rela-
tively modest percentage of DCs in TD volunteers up-regulated this molecule after typhoid di-
agnosis. The peak up-regulation was observed at the TD-48h and TD-96h time points (Fig 6G
and 6H). In contrast, CD21 expression, except for a modest increase 1 day after challenge, re-
mained unchanged compared to pre-challenge in NoTD volunteers (Fig 6I). We also evaluated
the gut migration potential of DCs by studying changes in the expression of integrin α4β7;
however, no significant changes following challenge were detected in either TD or NoTD vol-
unteers (S1C and S1D Fig).
Ability of DC to bind S. Typhi
The ability of DCs to bind S. Typhi was evaluated as described above. In TD volunteers an in-
crease in the interaction of S. Typhi with DCs was evident after typhoid diagnosis with a peak
at TD-96h (Fig 7A). A more detailed analysis at this time point revealed that all 5 volunteers
evaluated showed increased avidity for the bacteria (Fig 7B). Remarkably, in NoTD volunteers,
as was observed in monocytes, a spike in the interaction with S. Typhi was present immediately
after challenge (D1), with varying degrees depending on the individual participants (Fig 7D).
Expression of gut homing activation markers is independent of S. Typhi
binding
The dependence of the studied molecules, alone or in combination, on the binding to S. Typhi
was explored in monocytes and DCs using boolean gates (S2 Fig). For this analysis, an arbitrary
gate to define the percentage of cells binding to S. Typhi (>0.5%), was used. These gates were
Fig 5. DCs levels in peripheral blood following infection with wt S. Typhi. The percentages of circulating DCs in TD (squares; n = 5) and NoTD
(diamonds; n = 3) volunteers were compared to the levels before wt S. Typhi challenge (A) as well as in subsequent days (B andC). The graphs display
mean ± SE.
doi:10.1371/journal.pntd.0003837.g005
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based on FMOs. These evaluations were performed only in samples from 48h post-TD, the
time point in which most of the markers showed significant up-regulation. Only the 5 most
prominent populations of 16 possible combinations, in monocytes and DCs are displayed (S2
Fig). These 5 populations account for>90% and>60% of the monocytes and DCs, respective-
ly. In monocytes, the most abundant population was the one co-expressing CD38 and CD40,
the frequency of these cells was significant higher (p<0.05) than the other ones, except for the
Fig 6. Changes in CD38, CD40 and CD21 expression in DCs following wt S. Typhi challenge. Shown in panelsA, D andG are the time courses of the
changes in CD38, CD40 and CD21 expression, respectively, in TD volunteers. Shown in panelsB, E andH are the data in individual volunteers at pre-
challenge (squares) and peak up-regulation times (TD-0h or TD-48h) (inverted triangles) for these markers in TD volunteers. The histogram insert contains
an example of the up-regulation for each marker, in a representative volunteer. Shown in panelsC, F and I are the time courses of expression of CD38, CD40
and CD21 in NoTD volunteers. Statistical significance compared to pre-challenge is indicated by: * p<0.05; **p<0.005 (Dunnett’s multiple comparison test).
doi:10.1371/journal.pntd.0003837.g006
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one expressing CD40 alone. However, the predominance of CD40+CD38+ and CD40+ cells
was independent of the binding to S. Typhi (S2A and S2B Fig), as indicated by the similar pat-
terns identified between the cells that interacted with S. Typhi and the ones that did not. Inter-
estingly, CD38+CD40+ and integrin α4β7+CD38+CD40+ populations were not statistically
different in S. Typhi- cells (S2B Fig). By contrast, in S. Typhi+ cells these populations showed
statistical significance (S2A Fig). Finally, when the S. Typhi+ and S. Typhi- cells were compared,
integrin α4β7+CD38+CD40+, integrin α4β7+CD40+ and CD38+CD40+ populations were statis-
tically higher in frequency in the S. Typhi- group than in the S. Typhi+ one.
In DCs, in the S. Typhi+ cells (S2C Fig) the most abundant population was the one expressing
CD40 alone followed by cells expressing CD38 alone. However, no statistical difference was
found between the 5 populations evaluated. In S. Typhi- DCs, the most abundant population
was the one upregulating CD38 alone. There were no statistical differences between the popula-
tions evaluated in S. Typhi- cells (S2D Fig); however, when compared to the S. Typhi+ cells, upre-
gulation of CD38 alone was statistically significantly higher in S. Typhi- cells (S2C and S2D Fig).
Discussion
S. Typhi is a human restricted pathogen and no animal model is capable of reproducing all the
clinical aspects of this disease. Therefore, studies in humans are necessary to understand
Fig 7. Ability of DCs to bind S. Typhi following wild-type challenge. Time courses of the binding ability of circulating DCs from TD (A) and NoTD (C)
volunteers for S. Typhi (killed-fluorescently labeled). Shown in panelsB andD are the data of individual volunteers at peak time of binding in TD (TD-48h and
TD-96h) and NoTD (D1 Post-challenge) volunteers, respectively. Each volunteer is indicated by a defined symbol and color, as in Fig 4. The horizontal line
indicates the means.
doi:10.1371/journal.pntd.0003837.g007
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pathogen-human host immune interactions which can ultimately aid in the design of novel vac-
cines. The specimens used in the current study were collected as part of a parent study aiming at
developing a new human challenge model to study typhoid disease [11]. Macrophages are one of
the first lines of defense against Salmonella and at the same time a primary target of infection by
these microorganisms. However, several aspects of their in-vivo interaction remain unknown or
poorly understood. In the current study we aimed at studying changes in frequency, activation,
ability to bind S. Typhi and signaling induced by this microorganism in peripheral blood mono-
cytes and DCs of volunteers challenged with 104 CFU of wt S. Typhi (Quailes strain). Important-
ly, by comparing the results between TD and NoTD volunteers we aimed at furthering our
understanding of the role of these important components of the human innate immune response
when first encountering S. Typhi, and their potential to impact the development of disease.
No differences in the frequency of monocytes or DCs were identified before wild-type chal-
lenge, suggesting that it is not possible to predict which volunteers will develop disease by sim-
ply looking at the frequency of these cells in circulation (Figs 2A and 5A). Curiously, what
appears to be a small reduction in the percentage of monocytes was observed immediately after
typhoid diagnosis (TD), a finding consistent with the immunosuppression reported in animal
models [32, 33] as well as with the decrease in white blood cell counts reported in the parent
clinical trial [11]. However, the reductions in the percentages of monocytes as measured by
flow cytometry or by WCC was not statistically different (S1A and S1B Fig). The most likely
explanation for this phenomenon is that the “disappearance” of some of these cells from pe-
ripheral blood is due to their migration to the affected organs, such as the gut, as suggested by
the up-regulation of integrin α4β7 (Fig 3G and 3H). The lack of changes in the percentage of
DCs in TD volunteers, which correlates with the absence of changes in the expression of integ-
rin α4β7 supports this hypothesis (Fig 5B and S1 Fig).
The minor fluctuations in the percentage of circulating DCs in TD volunteers (Fig 5B) ini-
tially suggested that these cells either played a discrete role in typhoid or responded in a differ-
ent manner than monocytes. A more detailed analysis showed up-regulation of molecules
associated with DC activation (CD38 and CD40) indicating that these cells are likely to play a
role in typhoid (Fig 6A, 6B, 6D and 6E). Up-regulation of CD21 (Fig 6G and 6H) further con-
firms that DCs are activated in typhoid disease; however, the lack of changes in the expression
of integrin α4β7 (S1C and S1D Fig) suggests that DCs perform their function(s) in a different
organ than monocytes. Of note, CD21 is a molecule not usually associated with DCs, but with
follicular dendritic cells, which are not present in circulation. However, in-vitro experiments
have demonstrated that monocyte-derived DCs up-regulate this marker once they mature [34].
CD21 is the receptor for C3d, the final degradation product of the third component (C3) of
complement; therefore, up-regulation of this marker suggests that a small group of DCs have
an increased ability to bind opsonized bacteria, facilitating phagocytosis of the pathogen. This
enhanced phagocytosis can have 2 consequences: (1) bacteria use this mechanism to dissemi-
nate into the blood stream [35] or (2) it is a mechanism of defense that ultimately leads to de-
struction of the bacteria in the phagosome by reactive oxygen species (ROS) and other reactive
molecules. These consequences are not necessarily mutually exclusive, even though it is reason-
able to speculate that in the former scenario the bacteria remain alive while in the latter, the
bacteria are killed. However, even in the second scenario some bacteria may survive the effects
of ROS, resulting in infective organisms which could spread to local lymph nodes and systemi-
cally. Taken together, up-regulation of CD38, CD40 and CD21 suggest that DCs play a role in
typhoid disease. Nevertheless, the lack changes in expression of integrin α4β7 suggest that
these cells perform their function in a different organ/lymphoid tissue than monocytes.
Up-regulation of CD38 in monocytes and DCs is dependent on the presence of IFN-γ [36].
Interestingly, increased levels of IFN-γ and IP-10 were observed in the serum from TD
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volunteers. The presence of these cytokines was first evidenced in some volunteers 96 h before
typhoid diagnosis and elevated levels of IFN-γ were found in practically all the volunteers 48h
post-diagnosis (Blohmke, C et al., in preparation). Importantly, recent reports suggest that
CD38 synergizes with MHCII to enhance T cell proliferation [37], as well as CD83 expression
and induction of IL-2 production [38]. Therefore, CD38 might play a role both in antigen pre-
sentation and modulation of T cell activation and expansion. Finally, CD38 is a molecule that
has been associated with maturation of monocyte-derived DCs. Similar to CD38, CD40 was
up-regulated in both monocytes and DCs; however, there were some notable differences in the
observed kinetics, i.e., the peak expression was observed in DCs earlier (TD) than in monocytes
(TD-48h). These differences, however, were not statistically significant (S3 Fig).
In monocytes, expression and/or co-expression of CD38, CD40 and integrin α4β7 appeared
to be independent of bacteria binding since S. Typhi+ and S. Typhi- monocytes showed a simi-
lar pattern of up-regulation of these markers (S2A and S2B Fig). The statistical differences
identified in the populations between S. Typhi+ and S. Typhi- monocytes are likely the result of
the higher abundance of S. Typhi- cells (6–8 fold higher). Therefore, these data suggest that in
monocytes up-regulation of these molecules was more likely dependent on the cytokine milieu
rather than on the direct interaction with the microorganism. In DCs, even though some differ-
ences in the patterns of the populations between S. Typhi+ and S. Typhi- cells were identified
(S2A and S2B Fig), no statistical differences were identified within S. Typhi+ (S2A Fig) or S.
Typhi- cells (S2B Fig). Therefore, it appears that, similar to monocytes, expression and/or co-
expression of CD21, CD38 and CD40 is dependent of the cytokine environment and not on
their interaction with S. Typhi.
In the case of B and T cells it has been well documented that the induction of integrin α4β7
is dependent on the interaction with intestinal DCs or stromal mesenteric lymph node cells ca-
pable of producing retinoic acid (RA). These cells reside in Peyer’s patches (PP) and/or mesen-
teric lymph nodes (MLN) [39–42]. Integrin α4β7-expressing B and T cells identified in
peripheral blood are re-circulating cells that left PP or MLN upon being primed by intestinal
DCs. However, little is known concerning the expression of integrin α4β7 in circulating mono-
cytes, particularly in salmonellosis in humans. Circulating monocytes exhibit developmental
plasticity and upon entering tissues they can differentiate into macrophages or monocyte-de-
rived DCs [12, 14, 15, 43]. In our study, a major feature of circulating monocytes is their ability
to up-regulate integrin α4β7 during the typhoid disease days (Fig 3G and 3H). Less clear, how-
ever, was the mechanism behind this up-regulation since monocytes reaching tissues will be-
come terminally differentiated cells and are not expected to recirculate to peripheral blood.
Therefore, our data suggest that another, not yet identified mechanism, is responsible for up-
regulation of integrin α4β7 in monocytes. We can speculate that soluble factors (e.g., cytokine
(s) or other small molecule(s)) are ultimately responsible for enhancing the expression of integ-
rin α4β7 in monocytes during typhoid.
One of the most interesting findings is that monocytes and DCs in all NoTD volunteers
showed a spike in their ability to bind S. Typhi almost immediately after challenge (D1) (Figs
4D and 7C). Remarkably, following in-vitro stimulation with S. Typhi-LPS, monocytes from all
of these volunteers showed phosphorylation of NFκB and p38MAPK. Additionally, 2 of the
volunteers phosphorylated Erk1/2 (Fig 4F). These three proteins are associated with the TLR4
signaling pathway. On the other hand, TD volunteers also showed a spike in their ability to
bind S. Typhi; however, this occurred late in the infection and only in 2 of the 4 volunteers eval-
uated. Additionally, it appears that despite that these 2 volunteers showed increased binding of
the bacteria, the signaling pathways induced were different from the NoTD volunteers since
phosphorylation of p38MAPK was not detected and only one of the 2 phosphorylated NFκB.
Unfortunately, this type of analysis was not possible in DCs, mainly due to technological
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limitations (lack of mAbs that allow proper resolution of the DC population). Taken together
these findings suggest that the initial interaction of monocytes with S. Typhi and activation of
the appropriate signaling pathways might limit the ability of this microorganism to cause dis-
ease. In the case of NoTD volunteers we can hypothesize that the bacteria were “neutralized”
immediately after challenge, likely in the gut microenvironment, precluding progression to ty-
phoid disease. Whether this is due to effective destruction of the microorganisms in the phago-
some or other mechanism(s) remains to be explored. In the case of TD volunteers S. Typhi
avoided neutralization following challenge and was able to establish an infection. It seems that
monocytes from these volunteers have difficulty mounting an appropriate response as evi-
denced by their lack of an increased ability to bind S. Typhi early in infection and induction of
different signaling pathways. In these volunteers, clearance of the disease most likely will rely
more heavily on adaptive immune responses. It is important to notice that monocytes from TD
volunteers with reduced binding of S. Typhi (48h) showed de-phosphorylation of Erk1/2, and
NFκB (Fig 4C), which might indicate that phosphatases are particularly active in monocytes
from these participants. Taken together, these results further support the idea that different sig-
naling pathways are predominant in TD volunteers. We acknowledge, however, that since we
evaluated phosphorylation at a single time point (10 minutes stimulation), we might be captur-
ing a difference in the kinetics of phosphorylation and de-phosphorylation of the signaling
proteins. Therefore, future studies will be directed to evaluate in more detail the kinetics of the
signaling pathways associated with TLR4 activation in TD and NoTD volunteers.
In summary, in the current study we have demonstrated for the first time that circulating
monocytes and DCs are activated following exposure to wt S. Typhi in humans. As expected,
these cells showed different migration profiles and most likely functions during disease devel-
opment. Additionally, we have provided the first data suggesting that distinct early interactions
of phagocytes with S. Typhi might be critical for disease control. Activation of appropriate sig-
naling pathways might lead to effective activation of the cells which will ultimately limit bacte-
rial infection, thereby avoiding disease. It is unlikely that monocytes/macrophages and DCs are
the sole contributors to this phenomenon. A constellation of other innate and adaptive im-
mune responses might also contribute to limit the disease; however, the mechanisms by which
development of disease is controlled remain to be explored.
Supporting Information
S1 Fig. Percentage of monocytes in whole blood and expression of integrin α4β7 by DCs
following challenge with wt S. Typhi. Shown in panels A and B are the percentages of mono-
cytes in whole blood as determined by WCC (whole blood cell counts). These measurements
were obtained as part of routine blood hematology and biochemistry evaluations performed on
alternate days after challenge and at typhoid diagnosis. A routine haematology cytometer was
used to measure the total and differential white cell count in the samples collected from the
participants. Tests were run in the hospital clinical laboratory according to local and national
Standard Operating Procedures (SOPs) and with regular quality control (QC) standardization.
The measurements obtained in the clinical laboratory have already been published (Wadding-
ton CS, et al., Clinical Infectious Diseases, 2014). Panels C and D show kinetics of the expres-
sion of integrin α4β7 by DCs in TD and NoTD volunteers, respectively.
(DOCX)
S2 Fig. Evaluation of multi-marker expression by monocytes and DCs at TD 48h. To deter-
mine the dependence of upregulation of activation markers on the binding capacity to S.
Typhi, boolean gates for all the evaluated markers were used. For this analysis, the percentage
of cells binding to S. Typhi was determined using gates based on FMO stainings. Data are
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presented as % net change as related to baseline levels (pre-challenge) and represented in
box and whisker (90–10 percentile) plots. Only the five most dominant populations (of 16 pos-
sible combinations) are displayed for both monocytes and DCs. White bars indicate popula-
tions that bound to S. Typhi (S. Typhi+); while gray bars indicate the ones that did not (S.
Typhi-).  p< 0.05 (Bonferroni’s multiple comparison test). # p<0.05 comparison between S.
Typhi binding and non-binding groups (MannWhitney test).
(DOCX)
S3 Fig. Monocytes and DCs show different CD40 up-regulation kinetics. In TD volunteers
both monocytes and DCs up-regulated CD40 during typhoid disease days. However, the up-
regulation kinetics for this marker appeared slightly different since in DCs (open squares)
CD40 up-regulation peaked at TD-0h, while in monocytes (closed circles) maximum upregula-
tion was observed 2 days later (TD-48h). No statistically significant differences were observed
in the percentages of monocytes and DCs at peak times (Monocytes vs DCs).
(DOCX)
S4 Fig. Markers used to confirm identity of DCs. The identity of DCs was confirmed by the
lack of expression of lineage markers (CD3, CD56, CD66b) and expression of CD123 and
CD11c (shown in Fig 1). To further confirm the identity of DCs, expression of BDCA-1,
BDCA-2 and BDCA-3 were evaluated in CD14- HLA-DR+ cells. As controls for expression of
the previously mentioned markers, fluorescent minus one (FMO) for each marker was includ-
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